Cargando…

Non-Alcoholic Fatty Liver Disease Is an Independent Risk Factor for LDL Cholesterol Target Level

Although patients with non-alcoholic fatty liver disease (NAFLD) face a higher risk of cardiovascular disease (CVD), it is not known whether people with NAFLD are less likely to achieve optimal management of low-density lipoprotein (LDL) cholesterol than those without NAFLD. We aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jun-Hyuk, Lee, Hye Sun, Cho, A-Ra, Lee, Yong-Jae, Kwon, Yu-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037151/ https://www.ncbi.nlm.nih.gov/pubmed/33810315 http://dx.doi.org/10.3390/ijerph18073442

Ejemplares similares

Fat-to-Muscle Ratios and the Non-Achievement of LDL Cholesterol Targets: Analysis of the Korean Genome and Epidemiology Study
por: Cho, A-Ra, et al.
Publicado: (2021)

Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease
por: Lee, Jun-Hyuk, et al.
Publicado: (2021)

Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease
por: Du, Tingting, et al.
Publicado: (2017)

Differences among Three Skeletal Muscle Mass Indices in Predicting Non-Alcoholic Fatty Liver Disease: Korean Nationwide Population-Based Study
por: Cho, A-Ra, et al.
Publicado: (2021)

Fatty Liver Is an Independent Risk Factor for Elevated Intraocular Pressure
por: Lee, Jun-Hyuk, et al.
Publicado: (2022)

Association of non-high-density lipoprotein cholesterol trajectories with the development of non-alcoholic fatty liver disease: an epidemiological and genome-wide association study
por: Lee, Jun-Hyuk, et al.
Publicado: (2023)

Targeting LDL Cholesterol With LNA
por: Krieg, Arthur M
Publicado: (2012)

Comparison of Newly Proposed LDL-Cholesterol Estimation Equations
por: Jeong, Yong Whi, et al.
Publicado: (2023)

Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation
por: Kim, Eung Ju, et al.
Publicado: (2014)

Cutoff Points of Waist Circumference for Predicting Incident Non-Alcoholic Fatty Liver Disease in Middle-Aged and Older Korean Adults
por: Lee, Jun-Hyuk, et al.
Publicado: (2022)

Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Lee, Jun-Hyuk, et al.
Publicado: (2022)

Neck Circumference as a Predictor of Insulin Resistance in People with Non-alcoholic Fatty Liver Disease
por: Son, Da-Hye, et al.
Publicado: (2023)

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases
por: Malhotra, Pooja, et al.
Publicado: (2020)

Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies
por: Lee, Yong-ho, et al.
Publicado: (2016)

Association of Muscle Strength with Non-Alcoholic Fatty Liver Disease in Korean Adults
por: Lee, Sung-Bum, et al.
Publicado: (2022)

Association between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease
por: Young Kim, Sun, et al.
Publicado: (2022)

Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents
por: Chin, Justin, et al.
Publicado: (2020)

The effects of serum cholesterol, LDL, and HDL levels on gallstone cholesterol concentration
por: Atamanalp, S. Selcuk, et al.
Publicado: (2013)

Gender Differences in the Risk for Incident Non-Alcoholic Fatty Liver Disease According to the Transition of Abdominal Obesity Status: A 16-Year Cohort Study
por: Lee, Jun-Hyuk, et al.
Publicado: (2023)

Korean public and hospital data for estimating LDL-cholesterol
por: Lee, Taesic, et al.
Publicado: (2018)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
por: Storey, Benjamin C., et al.
Publicado: (2018)

LDL cholesterol is associated with higher AD neuropathology burden independent of APOE
por: Wingo, Aliza P, et al.
Publicado: (2022)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicenter Cross-Sectional Study
por: Imajo, Kento, et al.
Publicado: (2014)

Triglyceride to high-density lipoprotein cholesterol ratio is an independent predictor of liver fibrosis among pediatrics non-alcoholic fatty liver disease
por: Ting, Yi-Wen, et al.
Publicado: (2022)

Purple perilla extracts with α-asarone enhance cholesterol efflux from oxidized LDL-exposed macrophages
por: PARK, SIN-HYE, et al.
Publicado: (2015)

Intuitive Modification of the Friedewald Formula for Calculation of LDL-Cholesterol
por: Hong, Jinyoung, et al.
Publicado: (2023)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults
por: Lee, Jun-Hyuk, et al.
Publicado: (2022)

ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels
por: Jun, Ji Eun, et al.
Publicado: (2018)

Triglyceride Glucose-Waist Circumference (TyG-WC) Is a Reliable Marker to Predict Non-Alcoholic Fatty Liver Disease
por: Song, Seungah, et al.
Publicado: (2022)

Hypertriglyceridemia is a Major Factor Associated With Elevated Levels of Small Dense LDL Cholesterol in Patients With Metabolic Syndrome
por: Cho, Yonggeun, et al.
Publicado: (2015)

Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels <400 mg/dL
por: Moriyama, Kengo, et al.
Publicado: (2016)

Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness
por: Lee, Yong-ho, et al.
Publicado: (2017)

Cellular itinerary of LDL cholesterol
por: Vance, Jean E.
Publicado: (2022)

Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease
por: Lee, Kwang Seob, et al.
Publicado: (2022)

Effect of Animal and Industrial Trans Fatty Acids on HDL and LDL Cholesterol Levels in Humans – A Quantitative Review
por: Brouwer, Ingeborg A., et al.
Publicado: (2010)

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)
por: Langslet, Gisle, et al.
Publicado: (2020)

The quality of non-alcoholic fatty liver disease information resources for patients on the internet in Korea
por: So, In Tae, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ab6oor4aoh5dsl3o9qiaqpisq9